Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study of Intrasaccular Flow Disruption Devices for the Treatment of Intracranial Aneurysms

NCT07620626 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT07620626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07620626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study of Intrasaccular Flow Disruption Devices for the Treatment of Intracranial Aneurysms
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Observational
Overall status
Recruiting
Start date
June 10, 2026
Completion date
June 30, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm